Home | All trials

[RDF data]
Trial NCT00000310

Resource URI: http://static.linkedct.org/resource/trials/NCT00000310
PropertyValue
linkedct:brief_title Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
linkedct:collaborator_agency <http://static.linkedct.org/resource/collabagency/9042>
linkedct:condition <http://static.linkedct.org/resource/condition/2992>
linkedct:criteria Inclusion Criteria: Cocaine abuse or dependence Exclusion Criteria: Dependence on other drugs. Major psychiatric illness
linkedct:description Risperidone in low doses is compared with placebo in a 6-week randomized trial. Subjects also receive supportive counseling. Outcome measure include rating of behavior, mood, drug abuse, global function, and urine toxicology.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age 50 Years
linkedct:eligibility_minimum_age 18 Years
linkedct:enrollment 0 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:id NCT00000310
rdfs:label Trial NCT00000310
linkedct:lastchanged_date August 16, 2005
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/168298>
linkedct:nct_id NCT00000310
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Serotonin/Dopamine Antagonism of Cocaine Effect
linkedct:org_study_id NIDA-09330-2
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/34587>
linkedct:overall_status Terminated
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000310>
linkedct:phase Phase 2
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/16514>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/1801>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/25660>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/8107>
linkedct:secondary_id R01-09330-2
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:start_date January 1996
linkedct:study_design Treatment, Randomized, Double-Blind, Placebo Control
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study measures incorporate an appropriate integration of behavioral and neurobiological indices.
rdf:type linkedct:trials
linkedct:verification_date January 1996